Skip to main content
. 2022 Feb 28;28(4):704–712. doi: 10.1038/s41591-022-01694-6

Extended Data Fig. 3. Assessment of fungal microbiome characteristics at order level.

Extended Data Fig. 3

Fungal microbiome analyses were performed using n=52 stool samples from n=26 patients (n=18 patients in nivolumab/ipilimumab with CBM588 arm [n=11 responders and n=7 non- responders]; and n=8 [n=7 non-responders and n=1 responder] patients in nivolumab/ipilimumab arm). Taxa with a mean relative abundance less than 0.001 were summed as other.

Source data